58-17b-610.6. Hospital pharmacy dispensing prescription drugs.
289 words·~1 min read·
/ut/title-58/chapter-17b/58-17b-610-6·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Effective 5/6/2026
58-17b-610.6. Hospital pharmacy dispensing prescription drugs.
(1)As used in this section, "controlled substance" means a substance classified as a controlled substance under the Controlled Substances Act, Title II, Pub. L. No. 91-513 et seq., or Section 58-37-108 .
(a)Subject to Subsection (2)(b) , the division shall make rules, in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, in consultation with hospital pharmacies, to establish guidelines under which a hospital pharmacy may dispense a limited supply of a prescription drug to an individual who is no longer a patient in the hospital setting if:
(i)the individual is discharged from the hospital on the same day that the hospital pharmacy dispenses the prescription drug to the individual;
(ii)in the professional judgment of the practitioner, dispensing the drug is necessary for the patient's immediate needs;
(iii)the class A pharmacy with which the patient has an established pharmacy-patient relationship:
(A)is not open at the time of the patient's discharge; or
(B)unable to dispense the medication for any reason;
(iv)the hospital pharmacy dispenses a quantity of the prescription drug that is not more than a 72-hour supply; and
(v)dispensing the prescription drug complies with protocols established by the hospital pharmacy.
(i)A hospital pharmacy may dispense an opioid antagonist to a patient without satisfying Subsection (2)(a)(iii) .
(ii)A hospital pharmacy that dispenses an opioid antagonist to a patient under Subsection (2)(b)(i) shall accept as payment the wholesale acquisition cost at the time of dispensing.
(3)A hospital pharmacy, or a practitioner or pharmacist in the hospital, may dispense a prescription drug in accordance with rules made under Subsection
(2).
Amended by Chapter 362 , 2026 General Session